Terms and Conditions of Use
These terms govern your access and use of the Raxenorine website, outlining your rights and responsibilities. Please read carefully before engaging with any content or services.
Last revised December 28, 2025
Acceptance of Terms
By using this website, you acknowledge that you have read and agreed to these terms and all related policies. Continued use shows your acceptance of the conditions described here and in related sections.
Key Definitions
The following terms have specific meanings in this document for clarity.
'Site' refers to raxenorine.com, its features, and associated content online hosted by us.
'User' means anyone visiting, browsing, or interacting with the website or its resources.
'Content' covers all materials, articles, data, and information made available on the site.
'Service' refers to guidance, resources, or tools accessible via the website.
Using the Service
You agree to use the website only for lawful purposes, following these terms and all applicable regulations. Do not misuse or attempt unauthorized access to our systems or data.
Eligibility
Use of this site is intended for South African residents who are legally able to enter binding agreements. Use by anyone under 18 is not permitted.
18+ only as mandated by law.
User Responsibilities
You are responsible for actions taken with your access to the site and for respecting others' rights online.
Prohibited Uses
Users may not misuse the site as described below.
Intellectual Property
All site content is owned by Raxenorine or licensed partners. Reproduction, distribution, or unauthorized use is strictly prohibited except as permitted here or by law. Users may not claim proprietary rights to any content absent written agreement.
User-Submitted Content
When submitting any information, you certify it is accurate, lawful, and non-infringing. You are responsible for content you provide.
Your Content, Our Rights
By submitting content, you grant us a non-exclusive right to use, display, and moderate for site operation.
Privacy and Data Use
Your data is managed according to our Privacy Policy and all South African laws. By using the website, you consent to data use as described. See the Privacy Policy for details.
View Privacy PolicyDisclaimers and Limitations
Our resources offer guidance but are not substitutes for professional advisory services or legal requirements.
Key Disclaimers
Content is for informational purposes. Results vary and are not assured. We do not guarantee outcomes or returns from any advice given.
Limitation of Liability
We are not liable for losses or damages from use or reliance on our content, except as required by law.
Indemnification
You agree to defend and hold us harmless from claims, damages, or losses arising from your actions or use of the site.
Dispute Resolution
Any disputes will be managed as described below, following local jurisdiction.
Arbitration
Parties agree to confidential arbitration rather than litigation, whenever feasible and permitted by law.
This provision is not a waiver of statutory consumer rights.
Online Dispute Resolution
We encourage use of online channels for addressing issues. Details can be found by contacting our support team.
Submit Dispute OnlineSeverability
If any provision is unenforceable, the rest will remain in effect.
Entire Agreement
These terms, together with our policies, form the complete agreement regarding website use.
Governing Law and Jurisdiction
These terms are governed by South African law and relevant local regulations.
Termination
We reserve the right to suspend or terminate site access for breaches of these terms at any time and without prior notice.
Changes to Terms
Updates to these terms may be made. Notice will be posted. Continued use after updates means agreement to new terms.
Contact Information
Questions about these terms can be sent to our official contact details below.
Contact Email: content@raxenorine.com
Phone: +27(16)0065078
Address: 5 Buitengracht Street, CBD, Cape Town 8001 South Africa
Effective Date: Effective December 28, 2025
Version: 1.3